David, M., Faihy, A., Rolland, C., Edir, A., Canivet, A., Ligat, L., . . . Deraison, C. (2025). Bispecific nanobody® as a new pharmacological drug for the selective inhibition of Trypsin‐3. Wiley. https://doi.org/10.1111/bph.70100
Citazione stile Chigago Style (17a edizione)David, Melissa, et al. Bispecific Nanobody® as a New Pharmacological Drug for the Selective Inhibition of Trypsin‐3. Wiley, 2025. https://doi.org/10.1111/bph.70100.
Citatione MLA (9a ed.)David, Melissa, et al. Bispecific Nanobody® as a New Pharmacological Drug for the Selective Inhibition of Trypsin‐3. Wiley, 2025. https://doi.org/10.1111/bph.70100.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.